DAM
Derbend Asset Management’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $1.04M | Buy |
5,738
+1,265
| +28% | +$230K | 0.51% | 40 |
|
2023
Q4 | $693K | Buy |
4,473
+129
| +3% | +$20K | 0.4% | 49 |
|
2023
Q3 | $648K | Buy |
4,344
+126
| +3% | +$18.8K | 0.44% | 44 |
|
2023
Q2 | $568K | Buy |
4,218
+31
| +0.7% | +$4.18K | 0.38% | 38 |
|
2023
Q1 | $667K | Buy |
4,187
+30
| +0.7% | +$4.78K | 0.5% | 32 |
|
2022
Q4 | $672K | Sell |
4,157
-199
| -5% | -$32.2K | 0.54% | 38 |
|
2022
Q3 | $585K | Buy |
4,356
+5
| +0.1% | +$671 | 0.47% | 41 |
|
2022
Q2 | $666K | Sell |
4,351
-4,456
| -51% | -$682K | 0.56% | 36 |
|
2022
Q1 | $1.19M | Hold |
8,807
| – | – | 1.16% | 27 |
|
2021
Q4 | $1.19M | Sell |
8,807
-425
| -5% | -$57.5K | 1.16% | 27 |
|
2021
Q3 | $996K | Sell |
9,232
-806
| -8% | -$87K | 0.94% | 37 |
|
2021
Q2 | $1.13M | Buy |
+10,038
| New | +$1.13M | 1.05% | 33 |
|